Invesco Ltd. Increases Stock Position in Maximus, Inc. $MMS

Key Points

• Invesco Ltd. increased its stake in Maximus, Inc. by 11.1% during the 1st quarter, now owning approximately 0.49% of the company, valued at $18.98 million.
• Several institutional investors expanded their positions in Maximus, with notable increases such as UMB Bank growing its stake by 70.2% and NBC Securities Inc. raising its stake by a staggering 114,900% in the same quarter.
• Maximus recently announced a quarterly dividend of $0.30 per share, representing a 1.4% dividend yield, with 97.21% of its stock held by institutional investors.

Invesco Ltd. raised its holdings in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 11.1% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 278,312 shares of the health services provider's stock after acquiring an additional 27,718 shares during the period. Invesco Ltd. owned about 0.49% of Maximus worth $18,978,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Captrust Financial Advisors bought a new position in Maximus during the fourth quarter valued at approximately $276,000. GAMMA Investing LLC grew its holdings in shares of Maximus by 67.1% in the first quarter. GAMMA Investing LLC now owns 732 shares of the health services provider's stock worth $50,000 after purchasing an additional 294 shares during the last quarter. Blue Trust Inc. grew its holdings in shares of Maximus by 32.8% in the first quarter. Blue Trust Inc. now owns 1,228 shares of the health services provider's stock worth $84,000 after purchasing an additional 303 shares during the last quarter. Universal Beteiligungs und Servicegesellschaft mbH bought a new position in shares of Maximus in the first quarter worth approximately $2,115,000. Finally, Janney Montgomery Scott LLC grew its holdings in shares of Maximus by 70.5% in the first quarter. Janney Montgomery Scott LLC now owns 10,145 shares of the health services provider's stock worth $692,000 after purchasing an additional 4,196 shares during the last quarter. 97.21% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, Director Gayathri Rajan sold 7,913 shares of the firm's stock in a transaction on Friday, May 30th. The stock was sold at an average price of $72.38, for a total value of $572,742.94. Following the completion of the sale, the director owned 14,205 shares of the company's stock, valued at $1,028,157.90. This trade represents a 35.78% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. 1.60% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen cut shares of Maximus from a "buy" rating to a "hold" rating in a report on Thursday, May 15th. One investment analyst has rated the stock with a Buy rating, Based on data from MarketBeat.com, Maximus has an average rating of "Buy" and a consensus price target of $90.00.

Maximus Trading Up 1.8%

Shares of Maximus stock traded up $1.5160 on Friday, hitting $86.9260. The stock had a trading volume of 517,681 shares, compared to its average volume of 653,839. The stock's 50-day simple moving average is $74.51 and its two-hundred day simple moving average is $71.04. Maximus, Inc. has a one year low of $63.77 and a one year high of $93.94. The stock has a market cap of $4.90 billion, a price-to-earnings ratio of 16.01 and a beta of 0.60. The company has a quick ratio of 2.27, a current ratio of 2.27 and a debt-to-equity ratio of 0.91.

Maximus (NYSE:MMS - Get Free Report) last announced its quarterly earnings results on Thursday, August 7th. The health services provider reported $2.16 EPS for the quarter, topping analysts' consensus estimates of $1.39 by $0.77. Maximus had a return on equity of 24.44% and a net margin of 5.83%.The company had revenue of $1.35 billion during the quarter, compared to analyst estimates of $1.29 billion. During the same quarter last year, the firm posted $1.74 earnings per share. The firm's revenue was up 2.5% on a year-over-year basis. Maximus has set its FY 2025 guidance at 7.350-7.550 EPS. As a group, sell-side analysts predict that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Sunday, August 31st. Investors of record on Friday, August 15th will be paid a $0.30 dividend. The ex-dividend date of this dividend is Friday, August 15th. This represents a $1.20 dividend on an annualized basis and a yield of 1.4%. Maximus's dividend payout ratio (DPR) is presently 22.10%.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.